Cannabidiol Selectively Kills Cisplatin-Resistant Head and Neck Cancer Cells in Preclinical Study
A preclinical study reports that cannabidiol selectively impaired viability, migration, invasion, and clonogenic survival of cisplatin-resistant HPV-negative head and neck ...
